THE

DOSE

Daily news for smarter treatment decisions.

Latest Stories

Editorial cartoon: person walking through doorway on abstract shapes

FDA Proposes to Block Large-Scale GLP-1 Compounding in Major Access Shift

The FDA proposed removing semaglutide, tirzepatide, and liraglutide from its 503B bulks list, potentially ending large-scale compounding of affordable GLP-1 alternatives for good.

The Dose·May 1, 2026

FDA Plans July Meeting to Ease Peptide Restrictions After RFK Jr. Push

By RC Nelson

Editorial cartoon: shield with check mark on green waves

AI-Powered GLP-1 Telehealth Giant MEDVi Faces FDA Warnings and Lawsuits

By GLP1 Clinics News Desk

Editorial cartoon: scroll/document on navy/teal waves

Four States Drop GLP-1 Obesity Coverage as Federal Expansion Model Launches

By RC Nelson

Editorial cartoon: trending up arrow on teal/yellow waves

The Dose

CMS Launches BALANCE Model to Expand GLP-1 Access in Medicare and Medicaid

By GLP1 Clinics News Desk·Mar 24, 2026

Showing 1 of 5 articles.